Clinical reviews

← vista completa

Published on March 1, 2012 | http://doi.org/10.5867/medwave.2012.03.5337

Epidemiology, pathogenesis and genetics of atrial fibrillation

Epidemiología, patogénesis y genética de la fibrilación auricular

Alvaro Francisco Gudiño, Cristina Chediak

Abstract

For hundreds of years Atrial Fibrillation has raised great interest among researchers because of its presentation and the serious consequences that this entails. It has now become a main economic concern insofar as health expenditures are concerned. Its multifactorial etiology and its relationship to potentially preventable causes that affect millions of people around the world make this disease a very important target of investigation especially in its prevention. The aim of this paper is to define epidemiology, pathogenesis, and genetic factors related to atrial fibrillation. Review of literature included original articles and review articles selected from the MEDLINE database. Inclusion criterion was publication within the past ten years.

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Alvaro Francisco Gudiño

Hospital Enrique Garcés, Quito, Ecuador

Cristina Chediak

Hospital Enrique Garcés, Quito, Ecuador

Figures

Article has no figures.

Forum

No messages

History

Citation Gudiño AF, Chediak C. Epidemiology, pathogenesis and genetics of atrial fibrillation. Medwave 2012;12(03):e5337 doi: 10.5867/medwave.2012.03.5337

Submission date 25/11/2011

Acceptance date 15/02/2012

Publication date 01/03/2012

Index

Metrics

Not available at the moment.

Notes

Keywords

atrial fibrillation, oxidative stress, inflammation, arrhythmia, genes

Origin and peer review

con revisión externa por 3 revisores, a doble ciego

References

  1. Khasnis A, Thakur R. Atrial Fibrillation: A Historical Perspective. Cardiol Clin. 2009 Feb;27(1):1-12, vii. | CrossRef | PubMed
  2. Márquez M, Gómez-Flores J, Aranda-Faustro A, Cazares-Campos I, Cárdenas M. Avances recientes en la fisiopatología de la fibrilación auricular. Arch Cardiol Mex .2009;79(Supl 2.):18-25 | PubMed
  3. Schweitzer P, Keller S. A history of atrial fibrillation. Vnitr Lek. 2002 Dec;48: 1:24-6. | PubMed
  4. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 May;98(5):476-84. | CrossRef | PubMed
  5. Flegel KM. From delirium cordis to atrial fibrillation: historical development of a disease concept. Ann Intern Med. 1995 Jun 1;122(11):867-73. | PubMed
  6. Schmidt C, Kisselbach J, Schweizer P, Katus H, Thomas D. The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag. 2011;7:193-202. Epub 2011 Mar 31. | PubMed
  7. Chen L, Shen W. Epidemiology of atrial fibrillation: A current perspective. Heart Rhythm. 2007 Mar;4(3 Suppl):S1-6. Epub 2006 Dec 15. | PubMed
  8. Kannel W, Benjamin E Status of the epidemiology of atrial fibrillation.. Med Clin North Am. 2008 Jan;92(1):17-40, ix. | CrossRef | PubMed
  9. Camm J, Kirchhof P, Lip G, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation. Eur Heart J. 2010 Oct;31(19):2369-429. Epub 2010 Aug 29. | CrossRef | PubMed
  10. Savelieva I, Kakouros N, Kourliouros A, Camm J. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines Part I. Europace. 2011 May;13(5):610-25. | CrossRef | PubMed
  11. Shotan A, Garty M, Blondhein DS, Meisel SR, Lewis BS, Shochat M, et al. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS). Eur Heart J. 2010 Feb;31(3):309-17. Epub 2009 Oct 15. | PubMed
  12. Friberg L, Rosenqvist M. Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation. Europace. 2011 May; 13(5):626-33. | CrossRef | PubMed
  13. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98(10):946-52. | PubMed
  14. Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011 Oct; 13(10):1375-85 | CrossRef | PubMed
  15. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol. 2011 Jan-Feb; 27(1):74-90. | CrossRef | PubMed
  16. Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM. A comparison of outcome in patients with preoperative atrial fibrillation and patients in sinus rhythm. Ann Thorac Surg. 2011 Oct;92(4):1391-5. | CrossRef | PubMed
  17. Gbadebo T, Okafor H, Darbar D. Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J. 2011 Jul;162(1):31-7. | CrossRef | PubMed
  18. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010 Nov 16;122(20):2009-15. | CrossRef | PubMed
  19. De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L, et al. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail. 2007 May;9(5):502-9. Epub 2006 Dec 14. | PubMed
  20. Macfarlane PW, Murray H, Sattar N, Stott DJ, Ford I, Buckley B, et al The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace. 2011 May;13(5):634-9. | CrossRef | PubMed
  21. Camm J. Quality of Life in patients with Atrial Fibrillation. Rev Esp Cardiol. 2010 Dec;63(12):1393-5. | PubMed
  22. Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, et al. Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 2012 Feb;98(3):195-201. | CrossRef | PubMed
  23. Kourliourus A, Sevelieva I, Kiotsekoglou A, Jahangiri M, Camm J. Curent concepts in the pathogenesis of atrial fibrillation. Am Heart J. 2009 Feb;157(2):243-52. Epub 2008 Dec 24. | CrossRef | PubMed
  24. Markides V, Schilling R. Atrial Fibrillation: Classification, pathophysiology, mechanism and drug treatment. Heart. 2003 Aug;89(8):939-43. | CrossRef | PubMed
  25. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7; 105(3):315-8. | CrossRef | PubMed
  26. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008 Mar 11;117(10):1255-60. | CrossRef | PubMed
  27. Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol. 2010 May 25;55(21):2299-307. | CrossRef | PubMed
  28. Guler N, Ozkara C, Dulger H, Kutay V, Sahin M, Erbilen E, Gumrukcuoglu HA. Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery? Ann Thorac Surg. 2007 Feb; 83(2):532-7. | CrossRef | PubMed
  29. Guazzi M, Belletti S, Bianco E, Lenatti L, Guazzi MD. Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion. Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H921-8. | CrossRef | PubMed
  30. Allessie M, Boyden P, A. Camm J, Kléber, A, Lab M, Legato M, et al. Pathophysiology and Prevention of Atrial Fibrillation. Circulation. 2001 Feb 6;103(5):769-77. | PubMed
  31. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004 Mar;27(3):813-23. | CrossRef | PubMed
  32. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace. 2008 Jun;10(6):668-73. | CrossRef | PubMed
  33. De Caterina R, Ruigómez A, Rodríguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med. 2010 Sep 13;170(16):1450-5. | PubMed
  34. Santangeli P, Ferrante G, Pelargonio G, Dello Russo A, Casella M, Bartoletti S, et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. Europace. 2010 May; 12(5):649-54. | CrossRef | PubMed
  35. Adam O, Neuberger HR, Böhm M, Laufs U. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation. 2008 Sep 16; 118(12):1285-93. Circulation. 2008 Sep 16;118(12):1285-93. | CrossRef | PubMed
  36. Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem. 2007 Sep;53(9):1652-7. | CrossRef | PubMed
  37. Thomas G, Lerman BB. Expanding the Role of Statins in Post-Operative Atrial Fibrillation. Heart Rhythm. 2012 Feb;9(2):170-1. | CrossRef | PubMed
  38. Liu T, Korantzopoulos P, Shehata M, Li G, Wang X, Kaul S. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart. 2011 Jul;97(13):1034-40. | CrossRef | PubMed
  39. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine. 2004 Nov;25(2):73-83. | CrossRef | PubMed
  40. Sun Y, Hu D. The link between diabetes and atrial fibrillation: cause or correlation? J Cardiovasc Dis Res. 2010 Jan;1(1):10-1. | CrossRef | PubMed
  41. Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Seoane-Blanco A, Moure-González M, Varela-Román A, et al. Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol. 2011 Jun 6. | PubMed
  42. Rasoli S, Kakouros N, Harling L, Gukop P, Soni M, Athanasiou T, Kourliouros A. Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? Cardiol Res Pract. 2011; 2011:164078. | PubMed
  43. Tsai C, Lai L, Hwang J, Lin J, Chiang F. Molecular Genetics of Atrial Fibrillation. J Am Coll Cardiol. 2008 Jul 22;52(4):241-50. | CrossRef | PubMed
  44. Lehnart S, Ackerman M, Benson W, Brugada R, Clancy C, Donahue K, et al Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 2007 Nov 13;116(20):2325-45. | CrossRef | PubMed
  45. Conen D, Tedrow UB, Cook NR, Buring JE, Albert CM. Birth weight is a significant risk factor for incident atrial fibrillation. Circulation. 2010 Aug 24;122(8):764-70. | CrossRef | PubMed
  46. Lubitz SA, Yin X, Fontes JD, Magnani JW, Rienstra M, Pai M, et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA. 2010 Nov 24; 304(20):2263-9. | CrossRef | PubMed
  47. Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. | CrossRef | PubMed
  48. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2012 Jan;14(1):8-27. | CrossRef | PubMed
  49. Celebi S, Celebi O, Aydogdu S, Diker E. A peculiar medical cardioversion of atrial fibrillation with glucose infusion--a rare cause of atrial fibrillation: hypoglycemia. Am J Emerg Med. 2011 Jan;29(1):134.e1-3. | PubMed
  50. Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J. 2009 May;30(9):1128-35. | CrossRef | PubMed
  51. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009 Oct;32(10):1851-6. | CrossRef | PubMed
  52. Hatzinikolau E, Tziakas D, Hotidis A, Stakos D, Papanas N, et al Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol. 2006 Mar 1;97(5):659-61. Epub 2006 Jan 6. | CrossRef | PubMed
  53. Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg. 2011 May 23. | PubMed
  54. Ostgren CJ, Merlo J, Råstam L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab. 2004 Sep;6(5):367-74. | CrossRef | PubMed
  55. Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011 Jul 1;108(1):56-62 | CrossRef | PubMed
  56. Romano S, Di Mauro M, Fratini S, Guarracini L, Guarracini F, Poccia G, et al. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol. 2010 Dec 16;9:89. | CrossRef | PubMed
  57. Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart. 2012 Jan;98(2):133-8. | CrossRef | PubMed
  58. Chou CY, Kuo HL, Wang SM, Liu JH, Lin HH, Liu YL, et al. Outcome of atrial fibrillation among patients with end-stage renal disease. Nephrol Dial Transplant. 2010 Apr; 25(4):1225-30. | CrossRef | PubMed
  59. Hohnloser SH, Connolly SJ. Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope. Eur Heart J. 2011 Oct; 32(19):2347-9. | CrossRef | PubMed
  60. Böhm M, Thoenes M, Neuberger HR, Gräber S, Reil JC, Bramlage P, et al. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J. 2009 Jun; 30(11):1364-71 | CrossRef | PubMed
  61. Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006 Nov 27;166(21):2322-8. | CrossRef | PubMed
  62. Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, et al. Catheter ablation for atrial fibrillation in patients with obesity. Circulation. 2008 May 20; 117(20):2583-90. | CrossRef | PubMed
  63. Ruigómez A, Johansson S, Wallander MA, Rodríguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002 Apr;55(4):358-63. | CrossRef | PubMed
  64. Nagarakanti R, Saksena S, Hettrick D, Koehler JL, Grammatico A, Padeletti L. Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol. 2011 Oct; 32(1):7-15 | CrossRef | PubMed
  65. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Beshai JF, et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006 Apr 18;47(8):1683-8. | CrossRef | PubMed
  66. Mazza A, Bendini MG, Cristofori M, Nardi S, Leggio M, De Cristofaro R, et al. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables. Europace. 2009 Jul;11(7):902-9. | CrossRef | PubMed
  67. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol. 2002 May 1;155(9):819-26. | CrossRef | PubMed
  68. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med. 2001 Nov;250(5):382-9. | CrossRef | PubMed
  69. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation.The Framingham Heart Study. Circulation. 1994 Feb;89 (2):724-30. | PubMed
  70. Mattioli A, Bonatti S, Zennaro M, Mattioli G. The relationship between personality, socio-economic factors, acute life stress and development, spontaneous cardioversion and recurrences of acute lone atrial fibrillation. Europace. 2005 May;7(3):211-20. | CrossRef | PubMed
  71. Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010 Jul;31(14):1730-6 | CrossRef | PubMed
  72. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012 Feb;14(2):159-74. | CrossRef | PubMed
  73. Parvez B, Darbar D. Lone AF - etiologic factors and genetic insights into pathophysiolgy. J Atr Fibrillation. 2010 Dec 1;1(12):675-684. | PubMed
  74. Lévy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M.et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J. 1998 Sep;19(9):1294-320. | PubMed
  75. Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, et al. Catheter ablation for atrial fibrillation in patients with obesity. Circulation. 2008 May 20; 117(20):2583-90. | CrossRef | PubMed